Stock Research

Shares of Tesla remained under pressure on Friday, extending a weak run as investors weighed softer delivery expectations, geopolitical risks, and uncertainty surrounding CEO Elon Musk’s long-term strategy.  The stock fell 3% on Friday, adding to recent losses that have left it down sharply over the past three months. The electric-vehicle maker is now attempting… Continue reading Tesla stock struggles as delivery fears and Musk bets test investor faith

For the better part of a year, Wall Street has operated on a cynical yet profitable mantra – “Trump Always Chickens Out,” or the TACO trade. The strategy was simple. Whenever the White House issued a fire-and-brimstone threat – be it “Liberation Day” tariffs, the sudden annexation of Greenland, or military ultimatums – investors would… Continue reading TACO trade goes cold: why Wall Street isn’t buying Trump’s Iran extension

Shares of Meta Platforms extended their selloff on Friday, as mounting legal setbacks weighed on investor sentiment, but the recent decline also points to a deeper concern building beneath the surface. While US court verdicts have triggered immediate losses, investors are increasingly focused on the broader implications for Meta’s business model and future risk profile.… Continue reading Meta stock selloff continues, but a bigger risk looms

Nvidia shares remain under pressure, tracking a broader pullback in artificial intelligence-linked stocks. The stock fell 1.8% in early trading on Friday, after dropping 4.2% on Thursday to its lowest close since mid-December. It is now down around 10% for the year. The weakness reflects a shift in investor sentiment. AI-driven technology stocks, once market… Continue reading Nvidia stock slips below $170: why analysts see a buying opportunity

Royal Challengers Bengaluru, one of the most-loved cricket teams in the Indian Premier League (IPL), has a new owner. In a landmark transaction that values the IPL franchise at $1.78 billion, RCB was sold to a consortium led by the Aditya Birla Group, and include sports investor David Blitzer and private equity firm Blackstone. The… Continue reading RCB sold for $1.78B in India’s blockbuster IPL franchise deal

OpenAI is closing down its video generation platform Sora just months after its launch, marking a sharp shift in priorities at the company behind ChatGPT. The move comes as OpenAI pivots away from consumer-facing video tools and towards longer-term bets such as robotics and enterprise-focused artificial intelligence. The decision was communicated internally by CEO Sam… Continue reading Why is OpenAI shutting down Sora just months after launch?

US equities pulled back on Tuesday, giving up part of the previous session’s gains as rising oil prices and uncertainty around the ongoing Iran conflict weighed on investor sentiment.  Markets struggled to find direction amid conflicting signals on diplomacy and escalating geopolitical risks, while higher Treasury yields added further pressure. The S&P 500 fell 0.37%… Continue reading S&P 500, Dow Jones dip as Iran tensions cloud outlook

On Tuesday, Bitcoin saw a pullback while crypto-related stocks saw a decline.  Arm announced a move to in-house AI chip production while Jamie Dimon warned about AI-driven job losses in the US.  Bitcoin slips amid risk-off sentiment Bitcoin drifted lower on Tuesday, slipping back toward the $69,000 level as broader weakness in equities spilled over… Continue reading Evening digest: Bitcoin dips, Jamie Dimon warns on AI job risks

ImmunityBio Inc (NASDAQ: IBRX) is under immense pressure on March 24 after the US Food and Drug Administration (FDA) issued a scathing warning letter over the firm’s promotional tactics. Investors bailed on IBRX as regulators alleged the company and its billionaire founder, Dr. Patrick Soon-Shiong, used a TV ad and a high-profile podcast to make… Continue reading ImmunityBio stock price crash: buy the dip or sell the rip?